Filing Impact
Filing Sentiment
Form Type
6-K
Analyzing...
AKANDA CORP
Jan 8, 2026
Akanda Corp. Announces Reverse Stock Split
Jan 20, 2026
[Form 4] AKANDA CORP. Insider Trading Activity
Jan 20, 2026
[6-K] AKANDA CORP. Current Report (Foreign Issuer)
184.98k
144.51k
0.8%
1.31%
3.76%
Drug Manufacturers - Specialty & Generic
Healthcare
Canada
Toronto